A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: Results of a Belgian cross sectional study (BELPSO)

European Journal of Dermatology

Volumn 22, Issue 2, 2012, Pages 231-237

  Lambert, Julien ^a   Dowlatshahi, Emmilia Assal ^b   de la Brassinne, Michel ^c   Nijsten, Tamar ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Disease severity; Epidemiology; EuroQol 5D; Health Related Quality of Life; Psoriasis; Psoriasis characteristics

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTHRALGIA; ARTICLE; BELGIUM; BODY SURFACE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SCORING SYSTEM;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTHRALGIA; BELGIUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84859782099     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1623     Document Type: Article

References (36)

1. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974; 148(1): 1-18.
2. Farber EM, Bright RD, Nall ML, Psoriasis ML. A questionnaire survey of 2,144 patients. Arch Dermatol 1968; 98(3): 248-59.
3. Molin L. Psoriasis. A study of the course and degree of severity, joint involvement, socio-medical conditions, general morbidity and influences of selection factors among previously hospitalized psoriatics. Acta Derm Venereol Suppl (Stockh) 1973; 53: 1-125.
4. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13(3): 450-6.
5. Lomholt G. Prevalence of Skin Diseases in a Population; a Census Study from the Faroe Islands. Dan Med Bull 1964; 11: 1-7.
6. Lomholt G. Psoriasis on the Faroe Islands; a preliminary report. Acta Derm Venereol 1954; 34(1-2): 92.
7. Swanbeck G, Inerot A, Martinsson T, et al. Age at onset and different types of psoriasis. Br J Dermatol 1995; 133(5): 768-73.
8. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9(2): 136-9.
9. Dubertret L, Mrowietz U, Ranki A, et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155(4): 729-36.
10. Kawada A, Tezuka T, Nakamizo Y, et al. A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci 2003; 31(1): 59-64.
11. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3(1): 55-78.
12. Vasey FB EL. Psoriatic arthropathy. In: A C, editor. Spondylarthropathies. New York: Grune and Stratton; 1984.
13. Bennett R. Psoriatic arthritis. In: DJ M, editor. Arthritis and allied conditions. 9th ed. Philadelphia: Lea & Febiger; 1979. p. 645.
14. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005; 125(4): 659-64.
15. Nijsten T, Meads DM, de Korte J, et al. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J Invest Dermatol 2007; 127(10): 2315-22.
16. Finzi AF, Benelli C. A clinical survey of psoriasis in Italy: 1st AISP report. Interdisciplinary Association for the Study of Psoriasis. J Eur Acad Dermatol Venereol 1998; 10(2): 125-9.
17. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370(9583): 263-71.
18. de Jong EM. The course of psoriasis. Clin Dermatol 1997; 15(5): 687-92.
19. Farber EM, Nall L. Childhood psoriasis. Cutis 1999; 64(5): 309-14.
20. nd ed. Maiden: Blackwell Publishing; 2003.
21. Van de Kerkhof PC, Steegers-Theunissen RP, Kuipers MV. Evaluation of topical drug treatment in psoriasis. Dermatology 1998; 197(1): 31-6.
22. Hellgren L. Psoriasis. A statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls. Acta Derm Venereol 1964; 44(3): 191-207.
23. Meeuwis KA, de Hullu JA, de Jager ME, Massuger LF, van de Kerkhof PC, van Rossum MM. Genital psoriasis: a questionnaire-based survey on a concealed skin disease in the Netherlands. J Eur Acad Dermatol Venereol 2010.
24. Nijsten T, Looman CW, Stern RS. Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 2007; 143(9): 1113-21.
25. Nijsten T, Margolis DJ, Feldman SR, Rolstad T, Stern RS. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005; 52(3 Pt 1): 434-44.
26. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53(4): 573.
27. Sampogna F, Tabolli S, Abeni D, investigators IDIMPRoVE D. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol 2007; 157(3): 508-13.
28. Sampogna F, Tabolli S, Mastroeni S, et al. Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology 2007; 215(4): 341-7.
29. Zachariae R, Zachariae H, Blomqvist K, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146(6): 1006-16.
30. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137(3): 280-4.
31. Szende A. Measuring Self-Reported Population Health: An International Perspective based on EQ-5D: SpringMed publishing; 2004.
32. Tarride JE, Burke N, Bischof M, et al. A review of health utilities across conditions common in paediatric and adult populations. Health Qual Life Outcomes 2010; 8: 12.
33. Lillegraven S, Kristiansen IS, Kvien TK. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Ann Rheum Dis 2010.
34. Pickard AS, Wilke CT, Lin HW, Lloyd A. Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics 2007; 25(5): 365-84.
35. Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol 2000; 43(2 Pt 1): 229-33.
36. Moberg C, Alderling M, Meding B. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009; 161(2): 397-403.